A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

NEWARK, Del. and ATLANTA, Nov. 12, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to ...

The initiative could tackle the first-mover disadvantage some CDMOs believe deters early customers, but leaders at companies ...

A bipartisan group of senators and representatives introduced legislation to establish a National Biopharmaceutical Manufacturing Center of Excellence (COE), inspired by recommendations from the ...

SAN JOSE, Calif.--(BUSINESS WIRE)--The biopharmaceutical contract manufacturing market will reach $6.3 billion this year, a 12% increase from prior year. As pharmaceutical and biotechnology companies ...

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Detra Glinatsis has rejoined the company as Head of ...

The regulatory framework around biopharmaceutical manufacturing is exacting and continuously evolving. Companies must meet diverse global requirements while staying agile enough to deliver on ...

The University of Manchester's Centre of Excellence in Biopharmaceuticals (COEBP) has developed a biopharmaceutical manufacturing platform that allows rapid isolation of high-producing CHO cell ...

Celltrion Inc., a major South Korean biopharmaceutical company, has completed the acquisition of a biopharmaceutical manufacturing plant in the United States, the company said Friday, paving the way ...

Contract development and manufacturing organization (CDMO) Rentschler Biopharma has announced a partnership with biotechnology firm VarmX to manufacture VMX-C001 for Phase III development through ...

Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27. The plant, dubbed Modulus, represents an ...

Company implements next growth stage following successful strategic and operational developmentUwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed interim CEO LAUPHEIM, Germany and ...